Amferia is a Swedish biotechnology company specializing in antimicrobial wound-care solutions using bio-inspired peptides. Founded in Gothenburg, the company operates a clinical production site in Mölndal for testing and evaluating its healthcare products.
Subscribe to see Amferia’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Amferia is a life science company headquartered in Sweden. Its most recent funding round, Seed, raised $650,000 in January 2020. Xcout tracks 10 named people at Amferia, including Ingvar Karlsson (CFO).
4 more named people on record for Amferia, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $650,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.